An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors

Journal of Nuclear Medicine

Volumn 44, Issue 5, 2003, Pages 708-716

  Gabriel, Michael ^a   Decristoforo, Clemens ^a   Donnemiller, Eveline ^a   Ulmer, Hanno ^a   Rychlinski, Christine Watfah ^a   Mather, Stephen J ^b   Moncayo, Roy ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

99mTc; Hydrazinonicotinic acid; Scintigraphy; Somatostatin; Tyrosine octreotide

Indexed keywords

OCTREOTIDE[HYDRAZINONICOTINYL 3 TYROSINE TC 99M]; PENTETREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN DERIVATIVE; TRACER; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; DRUG DERIVATIVE; EDDA; EDETIC ACID; INDIUM; OCTREOTIDE; PENTETIC ACID; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN RECEPTOR; TECHNETIUM COMPLEX; TECHNETIUM TC 99M TRICINE HYDRAZINONICOTINYL PHE(1) TYR(3) OCTREOTIDE; TECHNETIUM TC 99M-TRICINE-HYDRAZINONICOTINYL-PHE(1)-TYR(3)-OCTREOTIDE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOCRINE TUMOR; FEMALE; FOLLOW UP; HUMAN; IMAGING; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPINAL CORD METASTASIS; CHEMISTRY; MIDDLE AGED; NEOPLASM; SCINTISCANNING;

ADULT; AGED; EDETIC ACID; FEMALE; HUMANS; INDIUM RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASMS; OCTREOTIDE; ORGANOTECHNETIUM COMPOUNDS; PENTETIC ACID; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN;

EID: 0038282731     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Reubi JC, Hacki WH, Lamberts SWJ. Hormones producing gastrointestinal tumors contain a high density of somatostatin receptors. J Clin Endocrinol Metab. 1987;65:1127-1134
2. Reubi JC, Kvols L, Krenning EP, Lamberts SWJ Distribution of somatostatin receptor in normal and tumour tissue. Metabolism. 1990;30(suppl 2):78-81.
3. Reubi JC, Kvols L, Krenning E, Lamberts SW. In vivo and in vitro detection of somatostatin receptors in human malignant tissues. Acta Oncol. 1991;30:463-468.
4. Reubi JC, Krenning E, Lamberts SW, Kvols L. In vitro detection of somatostatin receptors in human tumors. Digestion 1993;54:76-83.
5. Reubi JC, Schaer JC, Markwalder R, Waser B, Honsberger U, Laissue J. Distribution of somatostatin receptors in normal and neoplastic human tissues-recent advances and potential relevance Yale J Biol Med 1997;70:471-479.
6. Hofland LJ, Liu Q, Van Koetsveld PM, et al Immunohistochemical detection of somatostatin receptor subtypes, sst1 and sst2A in human somatostatin receptor positive tumors. J Clin Endocrinol Merab. 1999;84:775-780.
7. Reubi JC, Schar JC, Waser B, et al Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatm radiotracers selected for scintigraphic and radiotherapeutic use Eur J Nucl Med. 2000;27:237-282
8. Reubi JC, Waser B, Schaer JC, Laissue JA. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med. 2001;28:836-846.
9. Krenning EP, Kwekkeboom DJ, Bakker WH, et al. Somatostatin receptor scintigraphy with [111-In-DTPA-D-Phe] and [123-I-tyr)-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20:716-731.
10. Krenning EP, Kwekkeboom DJ, de Jong M, et al. Essentials of peptide receptor scintigraphy with emphasis on somatostatin analog octreotide. Semin Oncol. 1994; 21 (suppl 13):6-14.
11. Lamberts SWJ, Reubi JC, Krenning EP Somatostatin and the concept of peptide receptor scintigraphy in oncology Semin Oncol 1994,21(suppl 13):1-5
12. Kwekkeboom D, Krenning EP, de Jong M. Peptide receptor imaging and therapy. J Nucl Med. 2000;41:1704-1713.
13. 111In-pentetreotide J Nucl Med. 2001;42:1134-1138.
14. 111In-octreotide J Nucl Med 2000;41:1114-1119
15. 111In-labelled octreotide derivatives. Eur J Nucl Med. 2000;27:1318-1325
16. 3]-octreotide. Bioconjug Chem. 1999;10:431-438
17. Debray MP, Geoffroy O, Laissy JP, et al. Imaging appearances of metastases from neuroendocrine tumours of the pancreas Br J Radiol. 2001;74:1065-1070.
18. Krenning EP, Bakker WH, Breeman WA, et al. Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet. 1989;333:242-244
19. Lamberts SWJ, Hofland LJ, Van Koetsfeld PM, et al. Parallel in vivo and in vitro detection of functional somatostatin receptors in human pancreatic tumors, consequences with regard to diagnosis, localization, and therapy. J Clin Endocrinol Metabol. 1990;71:566-574.
20. Lamberts SWJ, Krenning EP, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev. 1991;12:450-482.
21. 111indium pentreotide scintigraphy. Semin Oncol. 1994;21:15-20.
22. Zimmer T, Ziegler K, Bader M, et al. Localization of neuroendocrine tumours of the upper gastrointestinal tract. Gut. 1994;35:471-475.
23. Rieger A, Rainov NG, Elfrich C, et al Somatostatin receptor scintigraphy in patients with pituitary adenoma. Neurosurg Rev 1997;20:7-12.
24. Alexander HR, Fraker DL, Norton JA, et al. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome. Ann Surg. 1998;228:228-238.
25. Berna L, Chico A, Matras-Gum X, et al. Use of somatoslatin analogue scintigraphy in the localization of recurrent medullary thyroid carcinoma Eur J Nucl Med. 1998;25:1482-1488.
26. Telischi EF, Bustillo A, Whiteman ML, et al. Octreotide scintigraphy for the detection of paragangliomas. Otolaryngol Head Neck Surg. 2000;122:358-362.
27. Haslinghuis LM, Krenning EP, De Herder WW, Reijs AE, Kwekkeboom DJ. Somatostatin receptor scintigraphy in the follow-up of patients with differentiated thyroid cancer J Endocrinol Invest 2001;24:415-422.
28. Mama T, Stolz B, Albert R, Bruns C, Koch P, Macke H. Synthesis, radiochemistry and biological evaluation of a new somatostatin analogue (SDZ 219-387) labelled with technectium-99m. Eur J Nucl Med. 1994;21:437-444.
29. 111In-DTPA- octreotide. Pept Res. 1996;9:144-150.
30. Vallabhajosula S, Moyer BR, Lister-James J, et al. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides. J Nucl Med. 1996;37:1016-1022.
31. Blum JE, Handmaker H, Rinne NA. The utility of a somatostatin-type receptor binding peptide radiopharmaceutical (P829) in the evaluation of solitary pulmonary nodules Chest. 1999;115:224-232.
32. 99mTc depreotide. Semin Nucl Med. 2002;32:92-96.
33. 111In- pentreotide scintigraphy. J Nucl Med. 2002;43:889-895.
34. Schillaci O, Scopinaro F, Angeletti S, et al. SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors. J Nucl Med 1996;37:1452-1456.
35. Lebtahi R, Cadiot G, Sarda L, et al. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroemero-pancreatic tumors. J Nucl Med. 1997;38:853-858.
36. Chili A, Fanti S, Savelli G, et al. Comparison of sumatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours. Eur J Nucl Med. 1998;25: 1396-1403.
37. Le Rest C, Bomanji JB, Costa DC, Townsend CE, Visvikis D, Ell PJ. Functional imaging of malignant paragangliomas and carcinoid tumours. Eur J Nucl Med. 2001;28:478-482.
38. 1-octreotide binding and somatostatin receptor subtypes in thyroid tumors. J Nucl Med. 2000;41:636-642.
39. 1-octieotide and a scintillation detector. Eur J Nucl Med. 2001;28:1456-1462.
40. 3]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results. Eur J Nucl Med Mol Imaging. 2002; 29:742-753.